Riverbridge Partners LLC Sells 26,949 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Riverbridge Partners LLC cut its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 8.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 283,261 shares of the company's stock after selling 26,949 shares during the quarter. Riverbridge Partners LLC owned 1.86% of U.S. Physical Therapy worth $20,497,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of USPH. Principal Securities Inc. raised its position in U.S. Physical Therapy by 24.7% in the fourth quarter. Principal Securities Inc. now owns 3,293 shares of the company's stock valued at $292,000 after purchasing an additional 653 shares during the last quarter. Principal Financial Group Inc. raised its position in U.S. Physical Therapy by 4.1% in the fourth quarter. Principal Financial Group Inc. now owns 83,091 shares of the company's stock valued at $7,371,000 after purchasing an additional 3,274 shares during the last quarter. Truist Financial Corp raised its position in U.S. Physical Therapy by 60.1% in the fourth quarter. Truist Financial Corp now owns 17,937 shares of the company's stock valued at $1,591,000 after purchasing an additional 6,736 shares during the last quarter. Venturi Wealth Management LLC raised its position in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares during the last quarter. Finally, Illinois Municipal Retirement Fund raised its position in shares of U.S. Physical Therapy by 3.6% during the fourth quarter. Illinois Municipal Retirement Fund now owns 8,351 shares of the company's stock worth $741,000 after acquiring an additional 292 shares during the last quarter.

Insider Buying and Selling

In related news, Director Nancy Ham sold 400 shares of the business's stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the transaction, the director now directly owns 2,594 shares in the company, valued at $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.00% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Trading Down 0.8%

Shares of USPH stock opened at $73.89 on Friday. The company has a market cap of $1.12 billion, a P/E ratio of 33.89, a PEG ratio of 3.58 and a beta of 1.45. The stock has a 50 day simple moving average of $73.83 and a two-hundred day simple moving average of $80.89. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The firm had revenue of $183.79 million during the quarter, compared to analysts' expectations of $176.78 million. During the same quarter last year, the firm posted $0.51 earnings per share. The company's revenue for the quarter was up 18.0% compared to the same quarter last year. Research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were issued a dividend of $0.45 per share. The ex-dividend date was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a yield of 2.44%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 82.57%.

Analysts Set New Price Targets

USPH has been the subject of a number of analyst reports. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Barrington Research lowered their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JMP Securities restated a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lowered their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy presently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.